冠心病预后风险模型研究进展
DOI:
作者:
作者单位:

(1.新疆医科大学公共卫生学院,新疆乌鲁木齐市 830011;2.新疆医科大学心血管病中心,新疆乌鲁木齐市 830054)

作者简介:

韩聪聪,硕士研究生,研究方向为代谢性心血管病,E-mail:2713385967@qq.com。

通讯作者:

基金项目:

新疆维吾尔自治区重点研发项目(2022B03022-1);新疆医科大学青年科技拔尖人才项目(XYD2024Q06)


Research progress on prognostic risk models for coronary heart disease
Author:
Affiliation:

1.School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang 830011, China;2.Center for Cardiovascular Disease, Xinjiang Medical University, Urumqi, Xinjiang 830054, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    冠心病(CHD)是全球范围内严重威胁人类健康的重大公共卫生问题。尽管治疗手段的进一步提高改善了部分患者的预后,但院内死亡率改善有限,不同地区和医疗机构间的治疗差异依然存在。精准的风险预测模型对医护人员识别高危人群、制定个性化干预策略和改善预后至关重要。近30年来,国内外已相继开发了十余个冠心病预后风险预测模型,这些模型在适用人群、预测结局、预测因子的选择以及预后随访时间上存在显著差异,对临床应用提出了不同的限制和要求。为此,本文系统性综述了国内外冠心病预后风险预测模型,深入分析其在算法设计、数据处理及临床应用中的特点,并重点探讨数据整合方法的优化、模型可解释性的提升及跨人群验证策略的改进,旨在为冠心病精准防治提供科学依据,为临床决策和公共健康管理提供有力支持,同时为基于多模态数据的医学模型开发提供重要参考和指导。

    Abstract:

    Coronary heart disease (CHD) is a major global public health issue that poses a serious threat to human health. Despite advances in treatment improving the prognosis for some patients, hospital mortality rates remain largely unchanged, and significant disparities in treatment outcomes persist across regions and medical institutions. Accurate risk prediction models play a critical role in identifying high-risk populations, formulating personalized intervention strategies, and improving patient outcomes. Over the past 30 years, more than a dozen CHD prognosis prediction models have been developed worldwide. These models differ significantly in terms of target populations, predicted outcomes, selected predictors, and follow-up durations, posing various limitations and requirements for clinical application. This article systematically reviews CHD prognosis prediction models developed globally, analyzes their characteristics in terms of algorithm design, data processing, and clinical application. It also focuses on optimizing data integration methods, enhancing model interpretability, and improving cross-population validation strategies. The aim is to provide a scientific basis for precise prevention and management of CHD, offer robust support for clinical decision-making and public health management, and serve as a valuable reference for the development of medical models driven by multi-modal data.

    参考文献
    相似文献
    引证文献
引用本文

韩聪聪,谢依热·木拉提,邱欣雨,赵倩.冠心病预后风险模型研究进展[J].中国动脉硬化杂志,2026,34(2):163~170.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-01-10
  • 最后修改日期:2025-03-11
  • 录用日期:
  • 在线发布日期: 2026-03-10